title: The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.
abstract: Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies, with an overall life expectancy of 6 months. Despite considerable advances in the understanding of the molecular mechanisms involved in the carcinogenesis of PDAC, the outcome of the disease was not significantly improved over the last 20 years. Although some achievements in molecular-targeted therapies have been made (that is, targeting the epidermal growth factor receptor by erlotinib), which already entered clinical settings, and despite the promising outcome of the FOLFIRINOX trial, there is an urgent need for improvement of the chemotherapy in this disease. A plethora of molecular alterations are thought to be responsible for the profound chemoresistance, including mutations in oncogenes and tumor suppressors. Besides these classical hallmarks of cancer, the constitutive or inducible activity of transcription factor pathways are characteristic changes in PDAC. Recently, three transcription factors-nuclear factor-κB (NF-κB), nuclear factor of activated T cells (NFAT) and nuclear factor-E2-related factor-2 (Nrf2)-have been shown to be crucial for tumor development and chemoresistance in pancreatic cancer. These transcription factors are key regulators of a variety of genes involved in nearly all aspects of tumorigenesis and resistance against chemotherapeutics and death receptor ligands. Furthermore, the pathways of NF-κB, NFAT and Nrf2 are functional, interacting on several regulatory steps, and, especially, natural compounds such as curcumin interfere with more than one pathway. Thus, targeting these pathways by established inhibitors or new drugs might have great potential to improve the outcome of PDAC patients, most likely in combination with established anticancer drugs. In this article, we summarize recent progress in the characterization of these transcription-factor pathways and their role in PDAC and therapy resistance. We also discuss future concepts for the treatment of PDAC relying on these pathways.
authors.affiliation: Laboratory of Molecular Gastroenterology and Hepatology, Department of Internal Medicine I, Kiel, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Arlt
authors.forename: H
authors.initials: H
authors.lastname: Schäfer
authors.forename: H
authors.initials: H
authors.lastname: Kalthoff
references.citation: Nat Cell Biol. 2002 Jul;4(7):540-4
references.pmid: 12080349
references.citation: Mol Cancer. 2011 Apr 13;10:37
references.pmid: 21489257
references.citation: Biochem Biophys Res Commun. 2007 Nov 3;362(4):816-21
references.pmid: 17822677
references.citation: Cancer Lett. 2014 Jan 28;342(2):231-7
references.pmid: 22450751
references.citation: Oncogene. 2001 Jul 12;20(31):4258-69
references.pmid: 11464292
references.citation: Cancer Lett. 2005 Jun 28;224(2):171-84
references.pmid: 15914268
references.citation: J Pathol. 2010 Mar;220(4):446-51
references.pmid: 19967722
references.citation: Eur J Cell Biol. 2011 Jun-Jul;90(6-7):450-5
references.pmid: 21129814
references.citation: Gastroenterology. 2011 Oct;141(4):1473-85, 1485.e1-7
references.pmid: 21763242
references.citation: Cancer Treat Rev. 2003 May;29 Suppl 1:41-8
references.pmid: 12738242
references.citation: Mol Cancer Res. 2009 Mar;7(3):425-32
references.pmid: 19258413
references.citation: Cancer Lett. 2013 May 28;332(2):346-58
references.pmid: 21078544
references.citation: Clin Nephrol. 2010 May;73(5):333-43
references.pmid: 20420793
references.citation: Cancer Cell. 2011 Oct 18;20(4):418-20
references.pmid: 22014567
references.citation: Eur J Cancer. 2009 Aug;45(12):2219-27
references.pmid: 19524433
references.citation: Cancer Lett. 2011 Jun 28;305(2):250-62
references.pmid: 21093147
references.citation: Int J Biochem Cell Biol. 2004 Jul;36(7):1166-70
references.pmid: 15109564
references.citation: Gastroenterology. 2009 Sep;137(3):1072-82, 1082.e1-6
references.pmid: 19501586
references.citation: Biochem Biophys Res Commun. 2008 Aug 15;373(1):151-4
references.pmid: 18555005
references.citation: Cancer Res. 2009 Jul 1;69(13):5592-600
references.pmid: 19531648
references.citation: FASEB J. 2005 Apr;19(6):620-2
references.pmid: 15670977
references.citation: Nat Rev Clin Oncol. 2011 Jul 05;8(8):452-3
references.pmid: 21727930
references.citation: Carcinogenesis. 2008 Jun;29(6):1235-43
references.pmid: 18413364
references.citation: Oncogene. 2011 Apr 7;30(14):1615-30
references.pmid: 21170083
references.citation: Clin Cancer Res. 2008 Sep 15;14(18):5656-62
references.pmid: 18794072
references.citation: Mol Cancer. 2010 Apr 16;9:80
references.pmid: 20398369
references.citation: JOP. 2010 May 05;11(3):199-202
references.pmid: 20442512
references.citation: Mol Biol Rep. 2012 Apr;39(4):4743-7
references.pmid: 21964605
references.citation: J Clin Endocrinol Metab. 2011 May;96(5):E763-71
references.pmid: 21346076
references.citation: Gut. 2009 Jul;58(7):900-2
references.pmid: 19520886
references.citation: J Clin Gastroenterol. 2010 Apr;44(4):286-8
references.pmid: 20216081
references.citation: Clin Cancer Res. 2012 Jan 1;18(1):280-9
references.pmid: 22010213
references.citation: Int J Mol Med. 2012 May;29(5):946-56
references.pmid: 22367622
references.citation: J Biol Chem. 2009 Apr 17;284(16):10935-46
references.pmid: 19218564
references.citation: Expert Rev Anticancer Ther. 2008 Jun;8(6):993-1002
references.pmid: 18533808
references.citation: Int J Cancer. 2003 Jul 20;105(6):735-46
references.pmid: 12767057
references.citation: Oncotarget. 2011 Aug;2(8):646-53
references.pmid: 21896960
references.citation: Pancreas. 2010 May;39(4):463-72
references.pmid: 20118824
references.citation: Oncogene. 2012 Mar 15;31(11):1468-74
references.pmid: 21822306
references.citation: Nat Rev Cancer. 2012 Jan 19;12(2):121-32
references.pmid: 22257950
references.citation: Oncogene. 2013 Oct;32(40):4825-35
references.pmid: 23108405
references.citation: Cancer Res. 2002 Feb 1;62(3):910-6
references.pmid: 11830551
references.citation: Eur J Cancer. 2011 Jan;47(2):199-205
references.pmid: 21051221
references.citation: Mol Endocrinol. 2011 Dec;25(12):2054-64
references.pmid: 21964595
references.citation: Cell Mol Life Sci. 2008 Jun;65(11):1631-52
references.pmid: 18324353
references.citation: Antioxid Redox Signal. 2010 Dec 1;13(11):1627-37
references.pmid: 20446773
references.citation: N Engl J Med. 2011 May 12;364(19):1817-25
references.pmid: 21561347
references.citation: J Biol Chem. 2011 Nov 25;286(47):40911-21
references.pmid: 21990354
references.citation: PLoS Med. 2006 Oct;3(10):e420
references.pmid: 17020408
references.citation: Mol Cancer Ther. 2010 Aug;9(8):2365-76
references.pmid: 20682644
references.citation: J Immunol. 2008 Dec 15;181(12):8441-9
references.pmid: 19050262
references.citation: Pharmacol Res. 2008 Nov-Dec;58(5-6):262-70
references.pmid: 18838122
references.citation: Nature. 2011 Jul 06;475(7354):106-9
references.pmid: 21734707
references.citation: Mol Cancer Res. 2006 Oct;4(10):715-28
references.pmid: 17050666
references.citation: Hepatogastroenterology. 2007 Oct-Nov;54(79):2141-5
references.pmid: 18251177
references.citation: Biochem Pharmacol. 2008 Dec 1;76(11):1485-9
references.pmid: 18694732
references.citation: Oncogene. 2013 May 23;32(21):2690-5
references.pmid: 22751123
references.citation: J Natl Cancer Inst. 2011 Aug 3;103(15):1190-204
references.pmid: 21743023
references.citation: Expert Opin Ther Targets. 2011 Oct;15(10):1183-96
references.pmid: 21819318
references.citation: Nutr Cancer. 2010;62(7):919-30
references.pmid: 20924967
references.citation: J Biol Chem. 2012 Mar 23;287(13):10021-10031
references.pmid: 22308036
references.citation: Med Oncol. 2010 Jun;27(2):430-3
references.pmid: 19434525
references.citation: Mol Cancer Ther. 2006 Sep;5(9):2251-60
references.pmid: 16985059
references.citation: EMBO J. 2006 Aug 9;25(15):3714-24
references.pmid: 16874304
references.citation: J Biol Chem. 2012 Mar 23;287(13):10556-10564
references.pmid: 22311972
references.citation: Cancer Sci. 2011 Apr;102(4):728-34
references.pmid: 21241417
references.citation: Gastroenterology. 2012 Feb;142(2):388-98.e1-7
references.pmid: 22079596
references.citation: Cancer Lett. 2012 Dec 1;325(1):26-34
references.pmid: 22743616
references.citation: Mol Cell Endocrinol. 2007 Nov 15;278(1-2):52-62
references.pmid: 17920186
references.citation: Cancer Res. 2009 Jul 1;69(13):5575-83
references.pmid: 19549912
references.citation: Cell Cycle. 2010 Aug 15;9(16):3131-2
references.pmid: 20724840
references.citation: Cell Cycle. 2008 Feb 1;7(3):297-303
references.pmid: 18235236
references.citation: Free Radic Res. 2010 Nov;44(11):1267-88
references.pmid: 20815789
references.citation: Nature. 2009 Mar 26;458(7237):438-44
references.pmid: 19325623
references.citation: Cancer Res. 2011 Mar 15;71(6):2260-75
references.pmid: 21278237
references.citation: Nat Immunol. 2011 Jul 19;12(8):715-23
references.pmid: 21772280
references.citation: Hepatobiliary Pancreat Dis Int. 2008 Apr;7(2):201-9
references.pmid: 18397859
references.citation: Cancer Chemother Pharmacol. 2011 Jul;68(1):157-64
references.pmid: 20859741
references.citation: Free Radic Biol Med. 2008 Aug 15;45(4):537-46
references.pmid: 18539158
references.citation: Antioxid Redox Signal. 2010 Dec 1;13(11):1649-63
references.pmid: 20367496
references.citation: Cancer Epidemiol. 2010 Oct;34(5):523-33
references.pmid: 20638930
references.citation: Expert Opin Ther Targets. 2010 Jan;14(1):45-55
references.pmid: 20001209
references.citation: Curr Oncol. 2010 Jun;17(3):9-16
references.pmid: 20567622
references.citation: Mutat Res. 2010 Aug 7;690(1-2):12-23
references.pmid: 19799917
references.citation: Cancer Discov. 2011 Jul;1(2):103-5
references.pmid: 22586351
references.citation: J Biochem. 2002 Jan;131(1):1-15
references.pmid: 11754729
references.citation: Cancer Res. 2010 Jul 1;70(13):5486-96
references.pmid: 20530669
references.citation: Cancer Res. 2010 Jun 15;70(12):5004-13
references.pmid: 20530687
references.citation: J Biol Chem. 2004 Apr 16;279(16):16452-62
references.pmid: 14679213
references.citation: Gastroenterology. 2002 Dec;123(6):2052-63
references.pmid: 12454861
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Cancer Cell. 2012 Jan 17;21(1):105-20
references.pmid: 22264792
references.citation: J Cell Biochem. 2001 Apr 2-27;82(1):110-22
references.pmid: 11400168
references.citation: J Biol Chem. 2009 May 15;284(20):13291-5
references.pmid: 19182219
references.citation: Br J Cancer. 2011 Mar 15;104(6):1038-48
references.pmid: 21364589
references.citation: Nat Rev Cancer. 2009 Nov;9(11):810-20
references.pmid: 19851316
references.citation: Cancer Lett. 2012 Apr 28;317(2):127-35
references.pmid: 22138436
references.citation: Curr Cancer Drug Targets. 2011 Jun;11(5):548-59
references.pmid: 21486220
references.citation: Cell Signal. 2011 May;23(5):883-92
references.pmid: 21262351
references.citation: J Nutr Biochem. 2011 May;22(5):426-40
references.pmid: 20655719
references.citation: Lancet. 2011 Aug 13;378(9791):607-20
references.pmid: 21620466
references.citation: Ann N Y Acad Sci. 2011 Jul;1229:184-9
references.pmid: 21793854
references.citation: Cancer Lett. 2012 Jul 28;320(2):158-70
references.pmid: 22406826
references.citation: Pancreas. 2006 Jan;32(1):101-9
references.pmid: 16340751
references.citation: Cancer Lett. 2010 Jul 1;293(1):99-108
references.pmid: 20137856
references.citation: Gastroenterology. 2010 Mar;138(3):1189-99.e1-2
references.pmid: 19900447
references.citation: Curr Drug Discov Technol. 2010 Mar;7(1):67-75
references.pmid: 20226002
references.citation: J Biol Chem. 2011 Nov 25;286(47):40725-33
references.pmid: 21926171
references.citation: Oncogene. 2010 Aug 26;29(34):4766-78
references.pmid: 20543863
references.citation: Cell Signal. 2010 Nov;22(11):1645-54
references.pmid: 20600852
references.citation: Cancer Res. 2010 Feb 15;70(4):1486-95
references.pmid: 20124483
references.citation: JOP. 2008 Jul 10;9(4):391-7
references.pmid: 18648128
references.citation: Oncogene. 2003 May 22;22(21):3243-51
references.pmid: 12761494
references.citation: N Engl J Med. 2010 Apr 29;362(17):1605-17
references.pmid: 20427809
references.citation: Cancer Chemother Pharmacol. 2010 May;66(1):151-8
references.pmid: 19774377
references.citation: Mol Cancer. 2008 Jul 24;7:64
references.pmid: 18652674
references.citation: Cancer Res. 2011 Aug 1;71(15):5081-9
references.pmid: 21676886
references.citation: Drugs. 2009 Nov 12;69(16):2227-43
references.pmid: 19852526
references.citation: Oncogene. 2006 Nov 30;25(56):7434-9
references.pmid: 16751802
references.citation: Pancreatology. 2005;5(6):514-29
references.pmid: 16110250
references.citation: Oncogene. 2001 Feb 15;20(7):859-68
references.pmid: 11314019
references.citation: J Mol Med (Berl). 2010 Jul;88(7):729-40
references.pmid: 20354842
references.citation: Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G356-67
references.pmid: 21546578
references.citation: Anticancer Agents Med Chem. 2006 May;6(3):187-208
references.pmid: 16712448
references.citation: Mutat Res. 2008 Jul-Aug;659(1-2):31-9
references.pmid: 18164232
references.citation: Int J Cancer. 2003 Apr 20;104(4):469-76
references.pmid: 12584745
references.citation: Pancreatology. 2010;10(4):416-22
references.pmid: 20720442
references.citation: J Pathol. 2012 Apr;226(5):723-34
references.pmid: 21984419
references.citation: Free Radic Biol Med. 2011 Jun 1;50(11):1599-609
references.pmid: 21402146
references.citation: Cancer Biomark. 2010;9(1-6):421-40
references.pmid: 22112488
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19589-94
references.pmid: 18048326
references.citation: Clin Cancer Res. 2010 Jul 15;16(14):3743-53
references.pmid: 20534738
references.citation: Oncogene. 2009 Nov 12;28(45):3983-96
references.pmid: 19734940
references.citation: Life Sci. 2008 Aug 15;83(7-8):293-300
references.pmid: 18640131
references.citation: Blood. 2006 Jun 1;107(11):4540-8
references.pmid: 16497967
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2322-7
references.pmid: 12606707
references.citation: Free Radic Biol Med. 2012 Aug 15;53(4):807-16
references.pmid: 22684019
references.citation: Trends Biochem Sci. 2009 Apr;34(4):176-88
references.pmid: 19321346
references.citation: J Biol Chem. 2011 Aug 19;286(33):28761-28771
references.pmid: 21628454
references.citation: Oncogene. 2011 Feb 3;30(5):505-20
references.pmid: 21057541
references.citation: Gut. 2013 Feb;62(2):310-6
references.pmid: 21997559
references.citation: Acta Clin Belg. 2011 Jan-Feb;66(1):10-7
references.pmid: 21485758
references.citation: Gut. 2009 Jul;58(7):949-63
references.pmid: 18829980
references.citation: Cancer Lett. 2013 May 28;332(2):313-24
references.pmid: 21345578
references.citation: Cancer Lett. 2010 May 1;291(1):90-8
references.pmid: 19880242